trending Market Intelligence /marketintelligence/en/news-insights/trending/lalBY0niVQLvgpcMN1Yfxg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Vical enters research collaboration with AnGes MG

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Vical enters research collaboration with AnGes MG

Vical Inc. entered into a research collaboration agreement with AnGes MG Inc.

Under the agreement, AnGes agreed to provide funding for the program up to a specified limit, and Vical agreed to conduct certain preclinical research related to a development program targeting chronic hepatitis B.

In exchange for the payment, AnGes will receive an option to negotiate exclusive rights in Japan related to the program.

The companies also agreed to share the costs of prosecuting and maintaining intellectual property rights arising from the research program after such costs reach a specified limit.